Professor Wolfgang Koenig
German Heart Center of Munich, Munich (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Imaging or biomarkers: which is superior in risk prediction?
Event: ESC Congress 2023
Topic: Cardiovascular Risk Assessment
Session type: Abstract Sessions
How to deal with residual cardiovascular risk in atherosclerotic disease? New pharmacotherapeutic options
Event: ESC Congress 2022
Topic: Cardiovascular Pharmacotherapy
Session type: Symposium
Prevention of cardiovascular diseases in the post-COVID19 era
Event: ESC Congress 2022
Topic: Prevention
Session type: Satellite Symposium
Cardiac biomarkers for atherosclerotic cardiovascular disease risk prediction
Event: ESC Congress 2021 - The Digital Experience
Topic: Biomarkers
Session type: Advances in Science
Emerging role of cardiac biomarkers in cardiovascular risk stratification
Event: ESC Preventive Cardiology 2021
Topic: Biomarkers
Session type: Satellite Symposium
Non-troponin biomarkers in acute coronary syndromes
Event: ESC Congress 2019
Topic: Biomarkers
Session type: Abstract Sessions
Emerging evidence-based approaches to reduce residual atherosclerotic risk
Event: ESC Congress 2018
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition & cardiovascular outcomes: review of lipid targets and treatment strategies (EBAC Accredited)
Event: ESC Congress 2017
Topic: Drug therapy
Session type: Satellite Symposium
PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?
Event: ESC Congress 2016
Topic: Atherosclerosis
Session type: Satellite Symposium - Experts on the Spot
The relevance of biomarkers: a never ending story
Event: ESC Congress 2016
Topic: Biomarkers
Session type: Moderated Posters
